International Clinical Trial: A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interactions of NB-9402 in Healthy Adult Volunteers - Part C Drug-Drug Interactions

Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ACTRN12626000651381) titled 'A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interactions of NB-9402 in Healthy Adult Volunteers - Part C Drug-Drug Interactions' on June 1.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group Type of endpoint: Safety

Primary Sponsor: Nura Bio Inc

Condition: Diseases of the nervous system Diseases of the nervous system Neurological - Other neurological disorders

Intervention: This study involves 1 single cohort of 8 participants. Each participant will receive a singl...